0363-0699 NDC - WAL ITIN ()

Drug Information

  • Product NDC: 0363-0699
  • Proprietary Name: Wal itin
  • Non Proprietary Name:
  • Active Ingredient(s):
  • Administration Route(s):
  • Dosage Form(s):

Labeler Information

Field Name Field Value
Labeler Name: Walgreen Company
Product Type:
FDA Application Number: ANDA076301
Marketing Category: ANDA
Start Marketing Date:2/13/2009
End Marketing Date:10/31/2023

Package Information

No. Package Code Package Description Billing Unit
10363-0699-031 BOTTLE in 1 CARTON (0363-0699-03) / 70 TABLET in 1 BOTTLE
20363-0699-4610 BLISTER PACK in 1 CARTON (0363-0699-46) / 1 TABLET in 1 BLISTER PACKEA
30363-0699-471 BOTTLE in 1 CARTON (0363-0699-47) / 150 TABLET in 1 BOTTLEEA
40363-0699-581 BOTTLE in 1 CARTON (0363-0699-58) / 40 TABLET in 1 BOTTLEEA
50363-0699-6020 BLISTER PACK in 1 CARTON (0363-0699-60) / 1 TABLET in 1 BLISTER PACKEA
60363-0699-651 BOTTLE in 1 CARTON (0363-0699-65) / 30 TABLET in 1 BOTTLEEA
70363-0699-721 BOTTLE in 1 CARTON (0363-0699-72) / 60 TABLET in 1 BOTTLE
80363-0699-751 BOTTLE in 1 CARTON (0363-0699-75) / 90 TABLET in 1 BOTTLEEA
90363-0699-871 BOTTLE in 1 CARTON (0363-0699-87) / 300 TABLET in 1 BOTTLEEA
100363-0699-951 BOTTLE in 1 CARTON (0363-0699-95) / 45 TABLET in 1 BOTTLEEA

NDC Record

Field Name Field Value Definition
PRODUCT NDC0363-0699The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAMEWal itinThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
START MARKETING DATE2/13/2009This is the date that the labeler indicates was the start of its marketing of the drug product.
END MARKETING DATE10/31/2023This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
MARKETING CATEGORY NAMEANDAProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
APPLICATION NUMBERANDA076301This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
LABELER NAMEWalgreen CompanyName of Company corresponding to the labeler code segment of the Product NDC.

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 12/6/2025

Previous Code
Next Code